Title: A Continued Conversation on the Maternal and Fetal Consequences of Rare Bleeding Disorders   
Date: Friday, February 3, 2017   
Time: 12:00 PM - 1:00 PM EST

Rare bleeding disorders (RBDs) represent 3-5% of all inherited deficiencies of coagulation factors. Pregnant women with RBDs may be at an increased risk of bleeding complications, particularly in the postpartum period. Autosomal disorders, such as severe Factor XIII deficiency and afibrinogenemia, result in high rates of spontaneous miscarriage, and recognition of their severity can lead to appropriate treatment and prevention, especially at childbirth. 

The paucity of information about the prevalence of RBDs hampered attempts to provide education and treatment options to healthcare providers and patients. A new multinational partnership is helping to capture information that can improve diagnostic opportunities and enhance access to treatments for bleeding. This Webinar will detail the issues, the new therapeutics and their appropriate application to the challenges.

Webinar Faculty: Dr. Meera Chitlur and Dr. Madhvi Rajpurkar